Nikolaus Marx

Summary

Affiliation: University of Ulm
Country: Germany

Publications

  1. request reprint
    Marx N, Walcher D. Vascular effects of PPARgamma activators - from bench to bedside. Prog Lipid Res. 2007;46:283-96 pubmed
    ..This review will focus on the vascular effects of PPARgamma activators and summarize the current knowledge of their modulatory function on atherogenesis and vascular disease. ..
  2. Merkel M. [Diabetic dyslipoproteinemia: beyond LDL]. Dtsch Med Wochenschr. 2009;134:1067-73 pubmed publisher
    ..Thus, statin therapy to decrease LDL cholesterol to target is the essential treatment for diabetic dyslipidemia to reduce cardiovascular risk. Other lipid lowering drugs can be added optionally...

Detail Information

Publications2

  1. request reprint
    Marx N, Walcher D. Vascular effects of PPARgamma activators - from bench to bedside. Prog Lipid Res. 2007;46:283-96 pubmed
    ..This review will focus on the vascular effects of PPARgamma activators and summarize the current knowledge of their modulatory function on atherogenesis and vascular disease. ..
  2. Merkel M. [Diabetic dyslipoproteinemia: beyond LDL]. Dtsch Med Wochenschr. 2009;134:1067-73 pubmed publisher
    ..Thus, statin therapy to decrease LDL cholesterol to target is the essential treatment for diabetic dyslipidemia to reduce cardiovascular risk. Other lipid lowering drugs can be added optionally...